These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 34592988)
1. The susceptibility of SERPINE1 rs1799889 SNP in diabetic vascular complications: a meta-analysis of fifty-one case-control studies. Chen J; Zhai C; Wang Z; Li R; Wu W; Hou K; Alzogool M; Wang Y; Cong H BMC Endocr Disord; 2021 Sep; 21(1):195. PubMed ID: 34592988 [TBL] [Abstract][Full Text] [Related]
2. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897 [TBL] [Abstract][Full Text] [Related]
3. Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach. Tziastoudi M; Dardiotis E; Pissas G; Filippidis G; Golfinopoulos S; Siokas V; Tachmitzi SV; Eleftheriadis T; Hadjigeorgiou GM; Tsironi E; Stefanidis I Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946835 [TBL] [Abstract][Full Text] [Related]
4. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis. Zhao L; Bracken MB; Dewan AT; Chen S Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602 [TBL] [Abstract][Full Text] [Related]
5. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population. Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255 [TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis. Zhang T; Pang C; Li N; Zhou E; Zhao K BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898 [TBL] [Abstract][Full Text] [Related]
7. The Impact of Vitamin D Receptor Gene Polymorphisms on the Susceptibility of Diabetic Vascular Complications: A Meta-Analysis. Song N; Yang S; Wang YY; Tang SQ; Zhu YQ; Dai Q; Zhang H Genet Test Mol Biomarkers; 2019 Aug; 23(8):533-556. PubMed ID: 31373850 [No Abstract] [Full Text] [Related]
8. Association of SERPINE1 rs1799889 polymorphism with arterial ischemic stroke in children: a systematic review and meta-analysis. Bahrami R; Dastgheib SA; Mirjalili H; Setayesh S; Shaker SH; Mirjalili SR; Noorishadkam M; Neamatzadeh H Nucleosides Nucleotides Nucleic Acids; 2021; 40(10):1018-1035. PubMed ID: 34429017 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis. Tabaei S; Omraninava M; Mehranfar S; Motallebnezhad M; Tabaee SS Biochem Genet; 2022 Oct; 60(5):1409-1445. PubMed ID: 35039979 [TBL] [Abstract][Full Text] [Related]
10. Effects of TNF-α-308G/A Polymorphism on the Risk of Diabetic Nephropathy and Diabetic Retinopathy: An Updated Meta-Analysis. Liu M; Shang M; Wang Y; Li Q; Liu X; Yang L; Zhang Q; Zhang K; Liu S; Nie F; Zeng F; Wen Y; Liu W Horm Metab Res; 2020 Oct; 52(10):724-731. PubMed ID: 32369834 [TBL] [Abstract][Full Text] [Related]
11. Elevated Expression of Plasminogen Activator Inhibitor (PAI-1/SERPINE1) is Independent from rs1799889 Genotypes in Arthrofibrosis. Bayram B; Owen AR; Dudakovic A; Bettencourt JW; Limberg AK; Morrey ME; Sanchez-Sotelo J; Berry DJ; Kocher JP; van Wijnen AJ; Abdel MP Meta Gene; 2021 Jun; 28():. PubMed ID: 33816122 [TBL] [Abstract][Full Text] [Related]
12. Association of tumor necrosis factor alpha promoter polymorphism (TNF-α 238 G/A and TNF-α 308 G/A) with diabetic mellitus, diabetic retinopathy and diabetic nephropathy: a meta-analysis. Meng N; Zhang Y; Li H; Ma J; Qu Y Curr Eye Res; 2014 Feb; 39(2):194-203. PubMed ID: 24073796 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer. Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413 [TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients. Guan H; Xia MD; Wang M; Guan YJ; Lyu XC Medicine (Baltimore); 2020 Aug; 99(35):e21558. PubMed ID: 32871871 [TBL] [Abstract][Full Text] [Related]
15. Association of PAI-1 rs1799889 Polymorphism with Susceptibility to Ischemic Stroke: a Huge Meta-Analysis based on 44 Studies. Jafari M; Jarahzadeh MH; Dastgheib SA; Seifi-Shalamzari N; Raee-Ezzabadi A; Sadeghizadeh-Yazdi J; Akbarian E; Neamatzadeh H Acta Medica (Hradec Kralove); 2020; 63(1):31-42. PubMed ID: 32422114 [TBL] [Abstract][Full Text] [Related]
16. Association between PPARγrs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis. Regine I; Husain RSRA; Aswathi RP; Reddy DR; Ahmed SSSJ; Ramakrishnan V Nefrologia (Engl Ed); 2020; 40(3):287-298. PubMed ID: 32417009 [TBL] [Abstract][Full Text] [Related]
17. Intracellular adhesion molecule-1 K469E gene polymorphism and risk of diabetic microvascular complications: a meta-analysis. Su X; Chen X; Liu L; Chang X; Yu X; Sun K PLoS One; 2013; 8(7):e69940. PubMed ID: 23922864 [TBL] [Abstract][Full Text] [Related]
18. The association of interieukin-6 polymorphism (rs1800795) with microvascular complications in Type 2 diabetes mellitus. Cui J; Zhang X; Guo C; Zhang L Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33016995 [TBL] [Abstract][Full Text] [Related]
19. 4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy. Xue C; Nie W; Zhou C; Yu F; Wang DM; Dai B; Mei CL Ren Fail; 2014 Apr; 36(3):332-8. PubMed ID: 24345290 [TBL] [Abstract][Full Text] [Related]
20. Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes. Buraczynska M; Wacinski P; Zukowski P; Dragan M; Ksiazek A J Diabetes Complications; 2014; 28(1):35-9. PubMed ID: 24075694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]